Low Albumin to Fibrinogen Ratio Predicts Poor Overall Survival in Esophageal Small Cell Carcinoma Patients: A Retrospective Study
Received 18 February 2020
Accepted for publication 30 March 2020
Published 21 April 2020 Volume 2020:12 Pages 2675—2683
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Professor Rudolph Navari
Yan Wang,* Jialong Li,* Shuai Chang, Kun Zhou, Guowei Che
Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Guowei Che Email email@example.com
Purpose: To explore the prognostic value of albumin to fibrinogen ratio (AFR) in patients with esophageal small cell carcinoma (ESCC).
Patients and Methods: Patients diagnosed with ESCC in West China Hospital from June 1, 2010, to July 31, 2019, were retrospectively reviewed. The AFR was defined as the ratio between the serum albumin level and fibrinogen level. The receiver operating characteristic curves were conducted to determine optimal cut-off values for survival prediction. Univariate and multivariate cox regression analyses were performed to clarify independent prognostic risk factors.
Results: A total of 88 ESCC patients were enrolled in our study with the median follow-up time of 6 months (range 1– 91 months). In the univariate analysis, the node metastasis, extraesophageal metastasis status, tumor-node-metastasis (TNM) stage and AFR were found to be potentially related with overall survival (OS) of ESCC patients. After the multivariate analysis, AFR [hazard ratio (HR)=3.487, 95% confidence interval (CI): 1.179– 10.312; P=0.024] and TNM stage (HR=6.044, 95% CI: 1.045– 34.974; P=0.045) were testified to be independent prognostic factors and low AFR (≤ 12.36) level was significantly associated with poor OS in ESCC patients.
Conclusion: The current study reported that AFR could serve as a novel prognostic indicator in ESCC and patients with AFR≤ 12.36 were more likely to have poor prognosis.
Keywords: albumin to fibrinogen ratio, esophageal small cell carcinoma, overall survival
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]